Strata Skin Sciences Shares Outstanding 2010-2023 | SSKN
Strata Skin Sciences shares outstanding from 2010 to 2023. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
| Strata Skin Sciences Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2023 | 35 |
| 2022 | 35 |
| 2021 | 34 |
| 2020 | 34 |
| 2019 | 32 |
| 2018 | 20 |
| 2017 | 3 |
| 2016 | 2 |
| 2015 | 2 |
| 2014 | 1 |
| 2013 | 1 |
| 2012 | 1 |
| 2011 | 1 |
| 2010 | 0 |
| 2009 | 0 |
| Strata Skin Sciences Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2023-12-31 | 35 |
| 2023-09-30 | 35 |
| 2023-06-30 | 35 |
| 2023-03-31 | 35 |
| 2022-12-31 | 35 |
| 2022-09-30 | 35 |
| 2022-06-30 | 35 |
| 2022-03-31 | 35 |
| 2021-12-31 | 34 |
| 2021-09-30 | 34 |
| 2021-06-30 | 34 |
| 2021-03-31 | 34 |
| 2020-12-31 | 34 |
| 2020-09-30 | 34 |
| 2020-06-30 | 34 |
| 2020-03-31 | 33 |
| 2019-12-31 | 32 |
| 2019-09-30 | 33 |
| 2019-06-30 | 31 |
| 2019-03-31 | 31 |
| 2018-12-31 | 20 |
| 2018-09-30 | 30 |
| 2018-06-30 | 14 |
| 2018-03-31 | 4 |
| 2017-12-31 | 3 |
| 2017-09-30 | 2 |
| 2017-06-30 | 2 |
| 2017-03-31 | 2 |
| 2016-12-31 | 2 |
| 2016-09-30 | 2 |
| 2016-06-30 | 2 |
| 2016-03-31 | 3 |
| 2015-12-31 | 2 |
| 2015-09-30 | 2 |
| 2015-06-30 | 2 |
| 2015-03-31 | 1 |
| 2014-12-31 | 1 |
| 2014-09-30 | 1 |
| 2014-06-30 | 1 |
| 2014-03-31 | 1 |
| 2013-12-31 | 1 |
| 2013-09-30 | 1 |
| 2013-06-30 | 1 |
| 2013-03-31 | 1 |
| 2012-12-31 | 1 |
| 2012-09-30 | 1 |
| 2012-06-30 | 1 |
| 2012-03-31 | 1 |
| 2011-12-31 | 1 |
| 2011-09-30 | 1 |
| 2011-06-30 | 1 |
| 2011-03-31 | 1 |
| 2010-12-31 | 0 |
| 2010-09-30 | 1 |
| 2010-06-30 | 0 |
| 2010-03-31 | 0 |
| 2009-12-31 | 0 |
| 2009-09-30 | 0 |
| 2009-06-30 | 0 |
| 2009-03-31 | 0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.019B | $0.033B |
| Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $38.774B | 21.57 |
| Inspire Medical Systems (INSP) | United States | $7.306B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.489B | 0.00 |
| 10x Genomics (TXG) | United States | $3.450B | 0.00 |
| Axonics (AXNX) | United States | $3.420B | 0.00 |
| Enovis (ENOV) | United States | $3.031B | 23.03 |
| Azenta (AZTA) | United States | $2.816B | 229.50 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.769B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.644B | 0.00 |
| Privia Health (PRVA) | United States | $2.114B | 93.79 |
| Schrodinger (SDGR) | United States | $1.760B | 0.00 |
| Phreesia (PHR) | United States | $1.275B | 0.00 |
| Omnicell (OMCL) | United States | $1.251B | 30.62 |
| Definitive Healthcare (DH) | United States | $0.829B | 0.00 |
| Standard BioTools (LAB) | United States | $0.737B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.601B | 0.00 |
| Talkspace (TALK) | United States | $0.502B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.334B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.313B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.313B | 0.00 |
| Pulmonx (LUNG) | United States | $0.289B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.171B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.158B | 0.00 |
| American Well (AMWL) | United States | $0.150B | 0.00 |
| Augmedix (AUGX) | United States | $0.147B | 0.00 |
| TruBridge (TBRG) | United States | $0.119B | 5.06 |
| Outset Medical (OM) | United States | $0.116B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.115B | 0.00 |
| 111 (YI) | China | $0.084B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.075B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.075B | 0.00 |
| HeartBeam (BEAT) | United States | $0.055B | 0.00 |
| Zepp Health (ZEPP) | China | $0.051B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.042B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.033B | 0.00 |
| Movano (MOVE) | United States | $0.027B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.024B | 0.00 |
| Cue Health (HLTH) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.020B | 0.00 |
| ETAO (ETAO) | United States | $0.019B | 0.00 |
| CareCloud (CCLD) | United States | $0.019B | 0.00 |
| Akili (AKLI) | United States | $0.018B | 0.00 |
| Biotricity (BTCY) | United States | $0.014B | 0.00 |
| Centogene (CNTG) | Germany | $0.012B | 0.00 |
| Transgenomic (PRPO) | United States | $0.010B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Syra Health (SYRA) | United States | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |